OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Stephen Tindal is director, Formulation and Site R&D Lead at Catalent Pharma Solutions.
April 02, 2018
Formulation expertise can smooth the transition of a prospective therapy from medicinal chemistry to drug dosage form.
August 01, 2014
Stephen Tindal from Catalent Pharma Solutions speaks with Pharmaceutical Technology Europe about advances in softgel technologies.